Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026, Apr 2026 and May 2026.
- Largest single sale: $632K (7,400 shares) of Kymera Therapeutics, Inc. on Mar 31, 2026. Filing
- Last sale before this period: Sep 2, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | CFO and CBO | Feb 6, 2025 | Sep 18, 2026 |
| Kymera Therapeutics, Inc. (KYMR) | Director | Mar 16, 2021 | Jun 25, 2026 |
Also a director at
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 17, 2026, Sionna Therapeutics, Inc.: 94,537 shares granted. 1 filing: 1
- May 11, 2026, Kymera Therapeutics, Inc.: sold 3,000 shares for $261K, under a disclosed plan; 3,000 shares acquired by exercising options. 1 filing: 1
- Apr 1, 2026, Kymera Therapeutics, Inc.: sold 4,600 shares for $393K, under a disclosed plan; 4,600 shares acquired by exercising options. 1 filing: 1
- Mar 31, 2026, Kymera Therapeutics, Inc.: sold 7,400 shares for $632K, under a disclosed plan; 7,400 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.